BONE BIOLOGICS CORPORATION
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $104.5K | $1.4M | $10.2M | $3.7M | $623.5K | $188.2K | — | — |
| SG&A Expense | $2.7M | $4.0M | $5.7M | $8.3M | $1.5M | $483.7K | — | — |
| Operating Income | $-2.8M | $-2.6M | $-20.4M | $-12.0M | $-3.0M | $-672.0K | $-5.2K | $-4.5K |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | — | — | — | $105.7K | $1.4M | $409.4K | — | — |
| Pretax Income | $-4.4M | $-7.0M | $-25.9M | $-13.9M | $-4.4M | $-1.1M | $-5.2K | $-4.5K |
| Income Tax Expense | $1.7K | $1.6K | $2.2K | $8.8K | $1.6K | $800 | — | — |
| Net Income | $-4.4M | $-7.1M | $-25.9M | $-13.9M | $-4.4M | $-1.1M | $-5.6K | $-4.9K |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | $-0.03 | $-0.06 | $-0.02 | $-0.02 | $-0.01 | $0.00 | $0.00 | $0.00 |
| EPS (Diluted) | $-0.03 | $-0.06 | $-0.02 | $-0.02 | $-0.01 | $0.00 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 793.5M | 129.8M | 1.16B | 966.4M | 728.1M | 327.8M | 150.0M | 150.0M |
| Shares Outstanding (Diluted) | 793.5M | 129.8M | 1.16B | 966.4M | 728.1M | 327.8M | 150.0M | 150.0M |
| Dividends Per Share | — | — | — | — | — | — | — | — |